Merck invests € 250M in new biotech development centre in Switzerland

Merck invests € 250M in new biotech development centre in Switzerland
Merck invests € 250M in new biotech development centre in Switzerland
07 July 2021 | News
image credit- businesswire
German firm Merck has announced the topping-out ceremony for its new Biotech Development Center in Corsier-sur-Vevey, Switzerland. 
This investment of € 250 million, which was announced in January 2020, is intended to help secure the capacities for a cost-efficient and agile provision of clinical study medication in the long term, to shorten the development time of novel biological active ingredients and to meet the challenge of the increasingly complex production of biotechnological substances to master the next generation.

Related Keywords

Germany , Corsier , Switzerland General , Switzerland , German , Canton Vaud , Peter Guenter , Philippe Leuba , Arianne Rouge , Marcus Claassen , Biotech Development Center , State Councilor Canton Vaud , Project Director , Global Healthcare Operations , Country Code Phone Number , ஜெர்மனி , சுவிட்சர்லாந்து , ஜெர்மன் , கேன்டன் வாட் , பயோடெக் வளர்ச்சி மையம் , ப்ராஜெக்ட் இயக்குனர் , உலகளாவிய சுகாதாரம் செயல்பாடுகள் , நாடு குறியீடு தொலைபேசி எண் ,